中文 | English
Return
Total: 449 , 1/45
Show Home Prev Next End page: GO
Author:(Xuejun LI)

1.Regulation of chromosome regulator EZH2 in cancer epigenetics and EZH2 targeted drugs in cancer therapy

Xin LI ; Xuejun LI

Chinese Journal of Pharmacology and Toxicology 2016;30(12):1273-1281

2.Drug targets discovery based on dynamic signal transduction networks

Juan WANG ; Xuejun LI

Acta Pharmaceutica Sinica 2010;0(01):-

3.Application of anti-CD20 monoclonal antibody in the treatment of active systemic lupus erythematosus

Jie LI ; Xuejun ZENG

Basic & Clinical Medicine 2006;0(02):-

4.Biologic characteristics and clinical application of varied nasal packing biomaterials

Xuejun ZHANG ; Zhiyu LI

Chinese Journal of Tissue Engineering Research 2007;0(49):-

5.Drug targets discovery based on dynamic signal transduction networks.

Juan WANG ; Xuejun LI

Acta Pharmaceutica Sinica 2010;45(1):1-8

6.Preventing diabetes:problems and prospects

Xuejun LI ; Shuyu YANG

China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(08):-

7.CT Staging of Gallbladder Carcinoma and Its Role in Evaluation of Surgical Resectability

Xuejun PING ; Chunlin LI

Journal of Practical Radiology 2001;0(10):-

8.Progress of Early Diagnosis in Primary Carcinoma of Gallbladder

Shoushuai LI ; Xuejun SUN

Chinese Journal of Bases and Clinics in General Surgery 2003;0(04):-

9.Hydroxyl radical and cerebral ischemia

Xuejun LI ; Fengyan SUN

Chinese Pharmacological Bulletin 1998;0(S1):-

10.Analysis of the Indication for 949 Sesarean Section

Xuejun LI ; Yanqin HE

Journal of Chinese Physician 2002;0(S1):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 449 , 1/45 Show Home Prev Next End page: GO